MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/1476-7961-9-11

Медицинская библиотека · Clinical and molecular allergy : CMA · 2011

T cell activity in successful treatment of chronic urticaria with omalizumab.

Sánchez-Machín Inmaculada, Iglesias-Souto Javier, Franco Andrés, Barrios Yvelise, Gonzalez Ruperto, Matheu Víctor

Редакционная статьяПеревод в очереди

Аннотация

Omalizumab, a humanized monoclonal anti-IgE antibody has the potential to alter allergen processing. Recently, it has been postulated the assessment of PHA-stimulated adenosine triphosphate (ATP) activity as maker of CD4+ T cells activity in peripheral blood cells. We present the case report of a 35-year-old woman with a history of chronic idiopathic urticaria and angioedema of 8 years of development with poor response to treatment. The patient was partially controlled with cyclosporine at doses of 100 mg/12 h. However, she was still developing hives daily. Finally treatment with omalizumab was started at dose of 300 mg every 2 weeks. The patient experienced a decrease in urticarial lesions 2 days after starting therapy. We also evaluated the effects of omalizumab therapy on the activity of peripheral blood CD4+ T cells from the patient, in order to determine the potential modification of anti-IgE therapy on the process of antigen presentation-recognition. Activity of CD4+ cells by ATP release was clearly increased demonstrating an enlarged CD4 activity. Omalizumab may be useful in the treatment of severe chronic urticaria. ATP activity of peripheral blood CD4+ T cells might be a non-subjective method to assess Omalizumab activity.

Для цитирования: Sánchez-Machín Inmaculada, Iglesias-Souto Javier, Franco Andrés, Barrios Yvelise, Gonzalez Ruperto, Matheu Víctor. T cell activity in successful treatment of chronic urticaria with omalizumab.. Clinical and molecular allergy : CMA. 2011. DOI: 10.1186/1476-7961-9-11.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.